Internal Medicine, Critical Care Medicine · Dallas, TX
NPI
1124213590
Since 2007
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5939 Harry Hines Blvs Hq1 200
Dallas, TX, 75390
Phone (214) 645-6485
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
748 services
Medicare patients, 2024
140
Average age 68
Drug cost, 2024
$308K
3,022 prescriptions
Company payments, 2025
$108
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vaidehi Kaza was code 99233 (hospital e&m - subsequent), 400 times for 63 patients. In total Vaidehi Kaza billed 748 services in 22 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 400 | 63 | $90.16 | $36K |
| 99215 Office E&M - Established | Office | 71 | 56 | $100.80 | $7,157 |
| 31624 Bronchoscopy | Facility | 57 | 35 | $74.84 | $4,266 |
| 94010 Pulmonary Function Testing | Office | 49 | 45 | $5.87 | $287 |
| 99152 Anesthesia | Facility | 46 | 31 | $9.35 | $430 |
| 94618 Pulmonary Function Testing | Office | 19 | 18 | $14.19 | $270 |
| 99239 Hospital Discharge Management | Facility | 17 | 16 | $88.81 | $1,510 |
| 99238 Hospital Discharge Management | Facility | 11 | 11 | $50.98 | $561 |
By year: 2022 $58K for 703 services; 2023 $62K for 906 services; 2024 $60K for 748 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vaidehi Kaza prescribed most often to Medicare patients was Warfarin Sodium, with 262 prescriptions and refills. In total Vaidehi Kaza wrote 3,022 Medicare prescriptions that cost $308K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Warfarin Sodium Generic | 262 | 505 | 83 | $2,755 |
| Valganciclovir Hcl Generic | 197 | 323 | 53 | $63K |
| Prednisone Generic | 186 | 407 | 71 | $1,412 |
| Azithromycin Generic | 176 | 366 | 61 | $2,507 |
| Tacrolimus Generic | 136 | 260 | 40 | $12K |
| Pantoprazole Sodium Generic | 121 | 271 | 42 | $1,025 |
| Metoprolol Tartrate Generic | 111 | 232 | 38 | $889 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 110 | 200 | 36 | $642 |
| Pravastatin Sodium Generic | 90 | 226 | 36 | $1,644 |
| Rosuvastatin Calcium Generic | 76 | 192 | 33 | $742 |
| Mycophenolate Mofetil Generic | 64 | 82 | 14 | $2,644 |
| Trazodone Hcl Generic | 54 | 92 | 19 | $271 |
| Valacyclovir Valacyclovir Hcl | 49 | 71 | 13 | $2,431 |
| Furosemide Generic | 49 | 104 | 23 | $207 |
| Gabapentin Generic | 45 | 69 | 14 | $655 |
Brand drugs: 175 claims; generic drugs: 2,809 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vaidehi Kaza $108 ($17.41 in general payments such as food, travel and fees and $90.35 for research) from 3 companies. The largest payer was Sanofi-Aventis U.S. LLC with $90.35.
| Company | Payments | Amount |
|---|---|---|
| Sanofi-Aventis U.S. LLC SNY | 1 | $90.35 |
| Paratek Pharmaceuticals, Inc. | 1 | $17.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.